- By Shuda Xia
Macerich Co (MAC), Dr. Reddy's Laboratories Ltd (RDY), Foot Locker Inc (FL), and Seneca Foods Corp (SENEB) have declined to their three-year lows.
Macerich Co (MAC) Declined to $57.85
The prices of Macerich Co (MAC) shares have declined to $57.85 on July 28, which is only 3.1% above the 3-year low of $56.06.
-
Warning! GuruFocus has detected 5 Warning Signs with MAC. Click here to check it out.
-
The intrinsic value of MAC
Macerich Co is an American self-managed real estate investment trust. It is the third-largest owner and operator of shopping centers in the United States, operating as a S&P 500 component. The company owns property across the United States, including property in California, Arizona, Washington, Missouri, and New York.
Macerich Co has a market cap of $8.2 billion; its shares were traded around $57.85 with a P/E ratio of 50.29 and P/S ratio of 8.10. The trailing 12-month dividend yield of Macerich Co stocks is 4.85%. The forward dividend yield of Macerich Co stocks is 4.64%. Macerich Co had an annual average earnings growth of 2.30% over the past 10 years.
On April 27 Macerich Co announced financial results for the first quarter 2017. The company reported a net income of $69.2 million or $0.48 per diluted share for the first quarter 2017 compared to net income of $420.9 million or $2.67 per diluted share for the first quarter 2016. The company also reported $133.6 million from funds from diluted operations for the quarter compared to $141 for the first quarter 2016.
Dr. Reddy's Laboratories Ltd (RDY) Declined to $36.79
The prices of Dr. Reddy's Laboratories Ltd (RDY) shares have declined to $36.79 on July 28, which is the new three year low.
Dr. Reddy's Laboratories Ltd is an Indian international pharmaceutical company based in Hyderabad, India. The company manufactures and markets a variety of pharmaceuticals, including over 190 medications and 60 active pharmaceutical ingredients, both in India and internationally. The company's primary products include diagnostic kits, critical care, and biotechnology products.
Dr. Reddy's Laboratories Ltd has a market cap of $6.47 billion; its shares were traded around $36.79 with a P/E ratio of 32.19 and P/S ratio of 2.78. The trailing 12-month dividend yield of Dr. Reddy's Laboratories Ltd stocks is 0.79%. Dr. Reddy's Laboratories Ltd had an annual average earnings growth of 22.80% over the past 10 years.
On July 27 Dr. Reddy's Laboratories Ltd announced first quarter 2018 financial results. The company reported consolidated revenues of 33.2 billion rupees, a year over year growth of 3%. The company also reported gross profit margins of 51.6%, a decline of around 460 basis points compared to last year. The company had a profit after tax of .6 billion rupees, which is 1.8% of total revenues.